Comparative Pharmacokinetics of YH14659

Summary

The objective of this study is to compare pharmacokinetics after single oral administration of 2 capsules of YH14659, a fixed-dose combination of clopidogrel and aspirin developed by Yuhan Corporation versus co-administration of Plavix (clopidogrel) and Astrix (aspirin) in healthy male volunteers.

Timeline

Start

2011-07

Primary completion

2011-11

Completion

2011-12

Drugs

Indications